Table 3.
Outcome | Total | No AKI | AKI | P |
---|---|---|---|---|
(n = 107) | (n = 45) | (n = 62) | ||
AKI stage during admission† | ||||
Stage 1 (≥1.5 × baseline)c | 11 (12) | 4 (10) | 7 (15) | 0.458 |
Stage 2 (≥2.0–2.9 × baseline)c | 11 (12) | 1 (2) | 10 (21) | 0.021 |
Stage 3 (≥3.0 × baseline or ≥4 mg/dl)c | 36 (40) | 5 (12) | 31 (65) | <0.001 |
Received RRT (%)c | 32 (30) | 3 (7) | 29 (47) | <0.001 |
Length of hospital stay (days) | 7.6 (5.6–12.9) | 5.9 (4.9–8.3) | 10.6 (6.6–18.0) | <0.001 |
Death (%)c | 35 (33) | 10 (22) | 25 (40) | 0.061 |
Study hours to death (%)c | 22.5 (12.5–51.0) | 40.1 (19.0–115.0) | 21.0 (10.0–38.0) | 0.074 |
All values are median (IQR) unless otherwise specified: cnumber (%). P < 0.05 using Mann U Whitney or Fischer’s exact test; significant in bold. †Highest KDIGO stage during admission in those that survived more than 24 h. Abbreviations: AKI = acute kidney injury; RRT = renal replacement therapy